Axitinib/sunitinib/zoledronic acid
Tài liệu tham khảo
Ishii G, et al. A case of papillary renal cell carcinoma type 2 resistant to sunitinib responded to second line therapy with axitinib. Nippon Hinyokika Gakkai Zasshi. The Japanese Journal of Urology 105: 129-133, No. 3, Jul 2014 [Japanese; summarised from a translation] - Japan